ClinicalTrials.Veeva

Menu

Exercise-induced Irisin in Individuals With Knee Osteoarthritis.

Ü

Ümmahani Kuş

Status

Completed

Conditions

Knee Osteoarthritis (Knee OA)

Treatments

Other: home exercise program
Behavioral: home exercise program + brisk walking exercise

Study type

Interventional

Funder types

Other

Identifiers

NCT06758388
E-11095095-050.04-225853

Details and patient eligibility

About

The goal of this prospective randomised controled study is to investigate the effect of 8-weeks brisk walking exercise on irisin levels, physical and psychosocial parameters in individuals with knee osteoarthritis, and the relationship between irisin levels and physical and psychosocial parameters. The main question it aims to answer is: does 8-weeks brisk walking exercise increase irisin levels and imoroves physical and psychosocial parameters and is the irisin level in relation with the physical and psychosocial parameters.

Full description

Irisin is a myokine secreted by skeletal muscle after physical activity. It improves subchondral bone density and quality by increasing osteoblast differentiation and proliferation and improves the mechanical support of cartilage. In addition, irisin promotes chondrocyte proliferation, inhibits chondrocyte apoptosis, and reduces the secretion of inflammatory factors and matrix metalloproteinases. As a result of all these, improvements in joint function may be achieved.

Besides, irisin can improve depressive mood in patients with depression, and irisin level is found to be positively correlated with sleep quality and negatively correlated with disease duration and disease activity in patients with rheumatoid arthritis.

This study aims to investigate the effect of an 8-week moderate-intensity brisk walking exercise program on irisin serum levels and physical and psychosocial parameters in individuals with knee osteoarthritis and the relationship between irisin levels and physical and psychosocial parameters.

Enrollment

46 patients

Sex

All

Ages

40 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with idiopathic knee OA
  • Stage 1-3 knee OA according to the Kellgren-Lawrence classification
  • Patients aged 40-65
  • Patients agreeing to participate in the study
  • Patients having physical and cognitive ability to participate in the exercise program

Exclusion criteria

  • History of depression and/or anxiety etc. psychiatric disease
  • Uncontrolled hypertension, uncontrolled heart rhythm disorders, history of hospitalization for cardiovascular reasons in the last 6 months
  • History of symptomatic pulmonary disease
  • Use of medication due to dyslipidemia and/or diabetes
  • Presence of acute inflammation or effusion in the knee joint
  • Presence of central or peripheral neurological disease that will cause loss of lower extremity muscle strength, sensation, and balance
  • Presence of a prosthetic joint in the knee and previous lower extremity surgery
  • Having received a physical therapy program in the last 6 months
  • Patients with severe visual or hearing impairment
  • Patients with severe peripheral vascular disorders
  • Presence of severe knee joint instability, ligament and meniscal damage
  • Being illiterate

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

46 participants in 2 patient groups

Control group
Other group
Description:
The control group will perform a home exercise program that includes progressive strengthening exercises.
Treatment:
Other: home exercise program
Intervention group
Active Comparator group
Description:
The intervention group will perform a home exercise program that includes progressive strengthening exercises and brisk walking exercise.
Treatment:
Behavioral: home exercise program + brisk walking exercise

Trial contacts and locations

1

Loading...

Central trial contact

Ümmahani Kuş, Physiotherapist

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems